The PI16 Antibody (PAC011226) is a valuable tool for researchers studying the PI16 protein, a potential tumor suppressor and regulator of cell proliferation and apoptosis. This polyclonal antibody is raised in rabbits and exhibits high reactivity with human samples, making it a reliable tool for Western blot applications. By binding specifically to the PI16 protein, this antibody enables precise detection and analysis in various cell types, making it ideal for studies in cancer research and cell biology.PI16, also known as peptidase inhibitor 16, is a key player in regulating cell growth and survival, making it a promising target for investigating cancer development and progression.
Its involvement in apoptosis and cell cycle control highlights its potential as a marker for tumor growth and therapeutic intervention. Researchers studying PI16 aim to unravel its complex role in cancer biology and explore its potential as a therapeutic target for cancer treatment.Overall, the PI16 Antibody (PAC011226) is a valuable resource for researchers investigating the role of PI16 in cancer biology and cell signaling pathways. Its high specificity and sensitivity make it a valuable tool for unraveling the mechanisms underlying cancer development and identifying potential therapeutic targets for cancer treatment.
PI16: Putative serine protease inhibitor. Belongs to the CRISP family. 2 isoforms of the human protein are produced by alternative splicing.Protein type: Membrane protein, integralChromosomal Location of Human Ortholog: 6p21.2
